Contents

Current Vascular Pharmacology, Volume 10 - Number 4

Editorial [Hot Topic: HDL Proteome: New Possibilities in the Treatment of Cardiovascular Disease (Guest Editors: Elena Burillo and Fernando Civeira)]

, 10(4): 391

Elena Burillo and Fernando Civeira


DOI: 10.2174/157016112800812773




HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease

, 10(4): 392 - 409

Jose M. Lou-Bonafonte, Montse Fito, Maria-Isabel Covas, Marta Farras and Jesus Osada


DOI: 10.2174/157016112800812827




Proteomics Investigations of HDL: Challenges and Promise

, 10(4): 410 - 421

Tomas Vaisar


DOI: 10.2174/157016112800812755




Lipid and Apoprotein Composition of HDL in Partial or Complete CETP Deficiency

, 10(4): 422 - 431

Eric J. Niesor, Elisabeth von der Mark, Laura Calabresi, Maurizio Averna, Angelo B. Cefalu, Patrizia Tarugi, Peter Nilsson and Gregor Dernick


DOI: 10.2174/157016112800812683




Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?

, 10(4): 432 - 441

Elena Burillo, Paula Martin-Fuentes, Rocio Mateo-Gallego, Lucia Baila-Rueda, Ana Cenarro, Emilio Ros and Fernando Civeira


DOI: 10.2174/157016112800812845




Editorial [Hot Topic: Current Antithrombotic Management of ST Elevation Acute Coronary Syndromes in the Cath Lab – A Paradigm Shift (Guest Editor: Bernardo Cortese)]

, 10(4): 442

Bernardo Cortese


DOI: 10.2174/157016112800812791




GP IIb/IIIa Inhibitors for STEMI: Still the Gold Standard or an Old Survivor?

, 10(4): 443 - 447

Giuseppe Musumeci, Matteo Baroni and Roberta Rossini


DOI: 10.2174/157016112800812737




Intracoronary Use of GP IIb/IIIa Inhibitors in Percutaneous Coronary Interventions

, 10(4): 448 - 453

Maria De Vita, Valentina Coluccia, Francesco Burzotta, Enrico Romagnoli and Carlo Trani


DOI: 10.2174/157016112800812764




Prasugrel During Primary Percutaneous Coronary Intervention: Evidence from Clinical Data

, 10(4): 454 - 457

Giuseppe Biondi-Zoccai, Antonio Abbate, Fabrizio D’Ascenzo, Marzia Lotrionte and Maria G. Modena


DOI: 10.2174/157016112800812782




Ticagrelor in ST-Elevation Myocardial Infarction

, 10(4): 458 - 462

Gregory A. Sgueglia, Giuseppe Tarantini and Giampaolo Niccoli


DOI: 10.2174/157016112800812728




Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach

, 10(4): 463 - 467

Alberto R. De Caterina, Italo Porto, Giovanni Luigi De Maria and Adrian P. Banning


DOI: 10.2174/157016112800812809




Cilostazol and Primary-PCI: Mirage or Good Alternative?

, 10(4): 468 - 471

Italo Porto, Domenico D’Amario and Filippo Crea


DOI: 10.2174/157016112800812854




Drug Coated Balloons in Acute Coronary Syndromes - Opportunities and Limitations

, 10(4): 472 - 475

Bruno Scheller, Yvonne Clever, Michael Bohm and Bodo Cremers


DOI: 10.2174/157016112800812692




In the Bivalirudin Era, Are We Still Looking for a Potent Antiplatelet Agent?

, 10(4): 476 - 478

Bernardo Cortese, Antonino Pitì, Adnan Kastrati and Dirk Sibbing


DOI: 10.2174/157016112800812700




Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies

, 10(4): 479 - 493

Patrizia Ferroni, David Della-Morte, Raffaele Palmirotta, Tatjana Rundek, Fiorella Guadagni and Mario Roselli


DOI: 10.2174/157016112800812836




Antiplatelet Therapy in Patients with Diabetes Mellitus

, 10(4): 494 - 505

Erik L. Grove and Soren Gregersen


DOI: 10.2174/157016112800812818




Blood Pressure Control and Antihypertensive Treatment

, 10(4): 506 - 511

Guido Grassi, Gino Seravalle, Fosca Quarti Trevano, Raffaella Dell’Oro and Giuseppe Mancia


DOI: 10.2174/157016112800812719




Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease

, 10(4): 512 - 520

Diljit Kaur-Knudsen, Stig E. Bojesen and Borge G. Nordestgaard


DOI: 10.2174/157016112800812746




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science